A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study. (Q46529068)
Jump to navigation
Jump to search
scientific article published on 3 June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study. |
scientific article published on 3 June 2005 |
Statements
A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study (English)
G Frasci
G D'Aiuto
P Comella
R Thomas
M Di Bonito
M D'Aiuto
G Romano
M R Rubulotta